作者
Paola Amero, Cristian Rodriguez-Aguayo, Rajan R Chaudhari, Shuxing Zhang, Anil K Sood, Gabriel Lopez-Berestein
发表日期
2019/7/1
期刊
Cancer Research
卷号
79
期号
13_Supplement
页码范围
368-368
出版商
The American Association for Cancer Research
简介
Aberrations in Gas6/AXL signaling is associated with many human diseases including ovarian cancer, where in patients expressing high levels of AXL have shorter overall survival than patients expressing low levels. Aptamers are short synthetic oligonucleotides (DNA or RNA) that can bind with highest specificity to various other macromolecules such as peptides, proteins and carbohydrates, based on their tertiary structures. Aptamers are similar in their functionality to antibodies in their specificity;
easier to manufacture than antibodies; have minimal side effects; and thus hold a high promise as therapeutics. The typical issues with the use of aptamers as therapeutic agents are their selectivity, stability, and bioavailability. We present the development of the next generation DNA aptamers, targeting p-AXL specifically to as a therapeutic in ovarian cancer (OC) by chemical modifications to their primary sequence …
学术搜索中的文章
P Amero, C Rodriguez-Aguayo, RR Chaudhari… - Cancer Research, 2019